Skip to main content

Table 1 Clinical characteristics of families having XPO5 variant

From: Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis

Family ID

Individual ID

Affected

Sex

Age (Years)

Age of onset (years)

KB

Hematuria

UP (g/24 h or qualitative)

Scr (μmol/L)

eGFR (ml/min/1.73m2)

BP (mmHg)

UA (μmol/L)

ACR (mg/mmol)

FS-133

III:2

2

M

42

23

FSGS

Negative

6.9

126

60.2

147/90

401

457.33

FS-133

II:1

0

M

60

2 + 

55

107.7

297

 < 2.5

FS-133

II:2

1

M

51

Negative

79

98.8

FS-133

II:3

2

M

63

56

1 + 

3 + 

138

46.5

611

74.03

FS-133

II:4

1

F

64

Negative

74

73.8

265

3.01

FS-133

III:3

2

F

37

37

Negative

69

97

225

12.61

CKD-05

II:3

2

F

24

24

FGGS

2 + 

0.179

332

15.9

110/70

512

CKD-05

I:1

2

M

60

60

Negative

Negative

186

33.1

130/80

446

CKD-05

I:2

1

F

59

Negative

Negative

56

98

351

CKD-05

II:2

0

F

32

3 ~ 7/HP

Negative

68

102.3

377

CKD-05

III:2

2

M

Died of ESRD at 20

20

  1. Affected, unaffected = 1, affected = 2, phenotype unknown = 0, KB Kidney biopsy, FSGS Focal segmental glomerulosclerosis, FGGS Focal global glomerulosclerosis, UP Urine protein, Scr Serum creatinine, BP Blood pressure, UA Uric acid, HP High power field, “-”, not available